Based in the United States, Cadenza Bio is a startup.
Cadenza Bio is a biotechnology company developing novel small-molecule oral drugs to treat demyelinating and inflammatory diseases by halting progression, promoting repair, and improving patient quality of life.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.